Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 2401 AL 2415

Neuropsychiatric manifestations in systemic lupus erythematosus and antiphospholipid syndrome: pathophysiology and current insights

Fujieda Y.

Immunol Med. 2026 Jun;49(2):212-222. doi: 10.1080/25785826.2025.2594828. Epub 2025 Nov 27.

Assessing the efficacy of dextromethorphan/quinidine in treating irritability in Huntington's disease

Zadegan SA, Calderon O, Karagas N, Patino J, Dongarwar D, Duncan B, Teixeira AL, Rocha NP, Furr Stimming E.

J Huntingtons Dis. 2026 Aug;15(3):332-341. doi: 10.1177/18796397251411112. Epub 2026 Jan 7.

Aberrant Mobility Disorder in an Uncontrolled Type 2 Diabetic - A Case Report on Diabetic Striatopathy

Mangudkar S, Singh DP, Malik SK, Shinde SG.

Ann Afr Med. 2026 Aug 1;25(Suppl 1):S113-S117. doi: 10.4103/aam.aam_523_25. Epub 2026 Jan 29.

A moderate-intensity exercise program during inpatient rehabilitation for middle stage Huntington's disease: A randomized controlled trial

Brusseau M, Soudrie B, Bachoud-Lévi AC, Bannier S, Bourdain F, Jenkins M, Natella PA, Bombenger N, Boiché J.

J Huntingtons Dis. 2026 Aug;15(3):453-467. doi: 10.1177/18796397261422975. Epub 2026 Mar 3.

An Open-Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease

Kumar R, Agarwal P, Anderson K, Claassen D, Dean M, Duker A, Scott B, Hoehn B, Mongan A, Lin P, Cahir-McFarland E, Taylor L, Morrison G, Yednock T, Keswani S, Kroon HA.

Mov Disord. 2026 Jun;41(6):1492-1501. doi: 10.1002/mds.70229. Epub 2026 Mar 5.

scVIP: personalized modeling of single-cell transcriptomes for developmental and disease phenotypes

Lai HY, Yoo Y, Tjärnberg A, Li R, He Z, Travaglini KJ, Qiao Q, Agrawal A, Kana O, van Velthoven C, Carroll J, Gillespie M, Mukherjee S, Fardo DW, Li X, Lein E, Gabitto MI.

bioRxiv [Preprint]. 2026 Jun 27:2026.04.20.717759. doi: 10.64898/2026.04.20.717759.

Roles of POU3F2 in Brain Development and Neuropsychiatric Disorders

Liu X, Xu H, Zhao Y, Yang J, Zhang L, Wang Z, Lim K, Zhang C, Lu L.

Dev Neurobiol. 2026 Jul;86(3):e70034. doi: 10.1002/dneu.70034.

Distress, not symptoms: Reframing psychological difficulties in neurodegenerative diseases of the motor system

Simpson J, Zarotti N.

Cortex. 2026 Jul;200:262-271. doi: 10.1016/j.cortex.2026.05.004. Epub 2026 May 9.

Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease

Findlay Black H, Levesley J, Kay C, Bortnick S, Javier K, Hayden MR.

J Huntingtons Dis. 2026 Aug;15(3):516-523. doi: 10.1177/18796397261443135. Epub 2026 May 27.

Systematic Review of the Huntington's Disease Drug Development Pipeline, 2014 to 2025

Konstantinova P, Townhill J, Bronzova J, Andreeva V, Sathe S, Sampaio C.

Mov Disord. 2026 Jun 1. doi: 10.1002/mds.70361. Online ahead of print.

Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities

Yang J, Li J, Hou X, Zheng Y, Zhao Z, Zhou T, Jing T, Kong J, Zhang G, Guo Y.

NPJ Aging. 2026 Jun 3. doi: 10.1038/s41514-026-00424-3. Online ahead of print.

Molecular interplay between Non-coding RNAs and BDNF in Neurodegenerative Disorders: a systematic review

Jalaiei A, Kiani Darabi AH, Sakkaki E, Rezazadeh M, Ghafouri-Fard S.

Mol Biol Rep. 2026 Jun 6;53(1):901. doi: 10.1007/s11033-026-12067-4.

Clinical telemonitoring and telerehabilitation of cognition in rare neurological diseases: a scoping review

Dini M, Maida E, Lavorgna L, Buizer A, Fanciulli A, Medijainen K, Nonnekes J, Ortigoza-Escobar JD, Salamon A, Timmann D, Vinciguerra C, Zádori D, Leocani L.

J Neurol. 2026 Jun 8;273(7):380. doi: 10.1007/s00415-026-13911-0.

Nanotechnology-enabled targeting strategies for neurodegenerative disorders: role of functionalized nanoparticles

Vishwakarma H, Chauhan A, Kaur L, Awasthi A.

J Pharm Pharmacol. 2026 Jun 2;78(6):rgag060. doi: 10.1093/jpp/rgag060.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias